Danaher Stock Forecast, Price & News

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher or view top-rated stocks.

Wall Street analysts have given Danaher a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Danaher wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Danaher saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 4,720,000 shares, a decline of 17.5% from the March 15th total of 5,720,000 shares. Based on an average daily trading volume, of 2,590,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 0.8% of the company's stock are sold short.
View Danaher's Short Interest.

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, April 22nd 2021.
View our earnings forecast for Danaher.

Danaher Co. (NYSE:DHR) announced its earnings results on Thursday, April, 22nd. The conglomerate reported $2.52 earnings per share for the quarter, topping analysts' consensus estimates of $1.67 by $0.85. The conglomerate earned $6.87 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a trailing twelve-month return on equity of 12.94% and a net margin of 18.05%. Danaher's revenue for the quarter was up 58.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.05 EPS.
View Danaher's earnings history.

Danaher's stock was trading at $139.37 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DHR stock has increased by 81.5% and is now trading at $252.92.
View which stocks have been most impacted by COVID-19.

Danaher announced a quarterly dividend on Tuesday, February 23rd. Stockholders of record on Friday, March 26th will be given a dividend of $0.21 per share on Friday, April 30th. This represents a $0.84 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date is Thursday, March 25th. This is an increase from Danaher's previous quarterly dividend of $0.18.
View Danaher's dividend history.

Danaher pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.34%. Danaher has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Danaher is 19.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 11.63% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.

Danaher issued an update on its first quarter 2021 Pre-Market earnings guidance on Tuesday, April, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.819-6.819 billion, compared to the consensus revenue estimate of $6.13 billion.

14 brokers have issued 1 year price targets for Danaher's shares. Their forecasts range from $190.00 to $280.00. On average, they expect Danaher's share price to reach $237.07 in the next twelve months. This suggests that the stock has a possible downside of 6.3%.
View analysts' price targets for Danaher or view top-rated stocks among Wall Street analysts.

27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Danaher include Roper Technologies (ROP), AMETEK (AME), Keysight Technologies (KEYS), Fortive (FTV), Cognex (CGNX), MKS Instruments (MKSI), Sensata Technologies (ST), Mesa Laboratories (MLAB), Senseonics (SENS), Hurco Companies (HURC), Focus Universal (FCUV), ClearSign Technologies (CLIR), Crawford United (CRAWA), Hickok (HICKA) and Sypris Solutions (SYPR).
View all of DHR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), The Home Depot (HD), The Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Danaher's stock is owned by a variety of institutional and retail investors. Top institutional investors include Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.25%), New York State Teachers Retirement System (0.11%), Welch & Forbes LLC (0.10%), Chevy Chase Trust Holdings Inc. (0.08%), Douglas Lane & Associates LLC (0.07%) and Retirement Systems of Alabama (0.06%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher.

DHR stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, New York State Teachers Retirement System, Chevy Chase Trust Holdings Inc., Sentry Investment Management LLC, Stock Yards Bank & Trust Co., Mckinley Capital Management LLC Delaware, Douglas Lane & Associates LLC, and Bartlett & Co. LLC. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, and William King.
View insider buying and selling activity for Danaher or view top insider-selling stocks.

DHR stock was acquired by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Bedrijfstakpensioenfonds Voor DE Media PNO, Defender Capital LLC., Clarus Group Inc., Parcion Private Wealth LLC, Calamos Wealth Management LLC, Everence Capital Management Inc., and Guinness Asset Management LTD.
View insider buying and selling activity for Danaher or or view top insider-buying stocks.

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DHR stock can currently be purchased for approximately $252.92.

Danaher has a market capitalization of $180.35 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis.

Danaher employs 69,000 workers across the globe.

The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex Germany GmbH, AB Sciex KK, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., AB Sciex Switzerland GmbH, AB Sciex UK Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, Aguasin SpA, Alltec Angewandte Laserlicht Technologie GmbH, Alpha Biotec Ltd., American Precision Industries, Applied Biosystems, Aquafine Corporation, Aquafine GmbH, Aquatic Informatics, Armstrong Tools, BCK Holdings S.à.r.l., Beckman Australia ApS, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biomedical GmbH, Beckman Coulter Biotechnology (Suzhou) Co. Ltd., Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited [irketi], Beckman Coulter Canada LP, Beckman Coulter Ceska republika s.r.o., Beckman Coulter Commercial Enterprise (China) Co. Ltd., Beckman Coulter España S.A., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd., Beckman Coulter Laboratory Systems (Suzhou) Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Mishima K.K., Beckman Coulter Nederland B.V., Beckman Coulter S.L., Beckman Coulter South Africa (Proprietary) Limited, Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Coulter do Brasil Ltda., Beckman Countler Nippon GK, BioTector Analytical Systems Ltd, Carnassial Corporation, Cepheid, ChemTreat, ChemTreat Inc., Coulter Electronics Pty. Limited, Cytiva, DANRAD ApS, DANRAD Holding ApS, DH Acquisition Holding GmbH, DH Alpha Limited, DH Business Services LLC, DH Canada Holding ULC, DH Europe Finance SA, DH Holding Italia SRL, DH Holdings Corp., DH Operations BV, DH Switzerland Finance SA, DH Technologies Development Pte Ltd., DM HoldCo GmbH, DTIL Ireland Holdings Ltd., DUKI (2006) Finance Limited, Danaher (Shanghai) Management Co. Ltd., Danaher Evolution GmbH, Danaher Medical ApS, Delta Consolidated Industries, Dental Imaging Technologies Corporation, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BVBA, Esko Brno S.r.o, Esko-Graphics BVBA, Esko-Graphics Inc., FFCL Cayman Ltd., FJ 900 Inc., Fluke, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, HIC Canada LP, Hach Company, Hach Lange GmbH, Hach Lange Sàrl, Hach Water Quality Analytical Instru. (Shanghai) Co. Ltd., HemoCue AB, Hybritech Incorporated, Hybritech International Incorporated, IDBS Group, IRIS International, Imaging Sciences International, Immunotech SAS, Immunotech Sro, Implant Direct Sybron Administration LLC, Implant Direct Sybron International LLC, Implant Direct Sybron Manufacturing LLC, Integrated DNA Technologies, Iris International Inc., Joslyn Holding Company LLC, KAVO Dental GmbH, KFL Finance Ltd., KaVo, KaVo Dental Holding GmbH, KaVo Kerr, KaVo do Brasil Indústria e Comércio Ltda., Kaltenbach & Voigt, Kaltenbach & Voigt GmbH, Kavo Dental Technologies LLC, Keithley Instruments, Kerr Corporation, KerrHawe SA, Kollmorgen, Laetus, Laetus GmbH, Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Instruments (Singapore) Pte Limited, Leica Microsystems, Leica Microsystems (UK) Limited, Leica Microsystems CMS GmbH, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems KK, Leica Microsystems Limited, Leica Microsystems Ltd. Shanghai, Leica Mikrosysteme (Austria) GmbH, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, Lipesa Colombia SA, Lumigen Inc., MDS Analytical Technologies, Marconi Data Systems, McCrometer Inc., Metrex Research LLC, Microtest, Molecular Devices, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Manufacturing Limited, Nobel Biocare, Nobel Biocare AB, Nobel Biocare Canada Inc., Nobel Biocare Deutschland GmbH, Nobel Biocare India Pvt.Ltd., Nobel Biocare Japan KK, Nobel Biocare Procera KK, Nobel Biocare Services AG, Nobel Biocare USA LLC, Ormco BV, Ormco Corporation, Pall, Pall (Canada) Limited, Pall (Schweiz) AG, Pall Acquisition LLC, Pall Aeropower Corporation, Pall Asia Holdings Inc., Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Biomedical Inc., Pall Deutschland Holding GmbH & Co., Pall Europe Limited, Pall Filter (Beijing) Co. Ltd., Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group, Pall ForteBio LLC, Pall France SAS, Pall GmbH, Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BVBA, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV, Pall Puerto Rico Inc., PaloDEX, PaloDEx Group OY, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., QH HoldCo GmbH, Radiometer, Radiometer, Radiometer America Inc., Radiometer GmbH, Radiometer K.K., Radiometer Medical Equipment (Shanghai) Co. Ltd., Radiometer Turku Oy, Raytek, Reytek Corporation, Sea-Bird Electronics Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., SpofaDental a.s., Sutron, Sybron Canada LP, Sybron Canada Limited Partner Company, Sybron Dental Specialties, Sybron Dental Specialties Inc., TH Finance Limited, Tektronix, Thomson Industries, Trojan Technologies, U.S. Peroxide LLC, VR Finance Company, VSS Monitoring, Videojet Argentina S.R.L., Videojet China Trading, Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies (I) Pvt. Ltd, Videojet Technologies Europe B.V., Videojet Technologies Inc., Viqua, Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Rite, X-Rite Asia Pacific Limited, X-Rite Europe GmbH, X-Rite Incorporated, XOS, and Zhuhai S.E.Z. Videojet Electronics Ltd..

Danaher was founded in 1984.

The official website for Danaher is www.danaher.com.

Danaher is headquartered at 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037.

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]